Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization

NANot yet recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

September 1, 2028

Primary Completion Date

September 1, 2030

Study Completion Date

September 1, 2031

Conditions
HIV (Human Immunodeficiency Virus)Clinical Decision Support System (CDSS)Antiretroviral Therapy, Highly ActiveINDIVIDUALIZED THERAPYAIDS (Acquired Immune Deficiency Syndrome)Personalized MedicinePrecision Medicine
Interventions
OTHER

smART (Smart Antiretroviral Therapy Assistant)

smART is a single-page, offline clinical decision support application that generates personalized HIV treatment recommendations by evaluating over 50,000 possible antiretroviral combinations. The user inputs patient-specific data including genotypic resistance profile, comorbid conditions, drug allergies, concomitant medications, and reproductive status (pregnant or planning pregnancy). smART performs all computations locally and does not store any patient information, ensuring complete data privacy.

OTHER

Traditional Prescribing resources

No additional interventions beyond standard clinical practice will be implemented for study participants. Treatment decisions will be guided by established HIV resources, including the Stanford HIV Database, the IAS-USA Drug Resistance Mutations Chart, and the NIH HIV Clinical Guidelines.

Trial Locations (1)

90033

Los Angeles General Medical Center, Los Angeles

All Listed Sponsors
collaborator

Los Angeles General Medical Center

OTHER

collaborator

AIDS Healthcare Foundation

OTHER

lead

Keck School of Medicine of USC

OTHER